AQST•benzinga•
Aquestive Therapeutics Announced Topline Results From Its Pediatric Study For Anaphylm (Epinephrine) Sublingual Film In Patients Aged 7 To 17 And Weighing Over 30kgs With A Personal History Of Allergic Reactions, FDA Application Acceptance Expected In Q2
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 1, 2025 by benzinga